Novo Nordisk Foundation Center for Stem Cell Medicine
Purpose
More people than ever live on our planet. While healthcare has become more accessible and advanced, many diseases and conditions, including numerous serious genetic and non-heritable conditions, still lack effective treatments. Stem cell medicine offers promising avenues to address this.
reNEW is dedicated to addressing both childhood and adult diseases, with the goal of developing novel therapies that utilise stem cells to transform lives through stem cell medicine. This encompasses stem cell-based cellular therapies and regenerative medicine, novel therapies identified via the use of human stem cell-derived tissue models, and gene editing to correct disease associated mutations.
Achieving these goals is only possible through excellence in fundamental research. This is the foundation for innovation in stem cell medicine, driving the discovery and development of groundbreaking therapies. As an international research university, the University of Copenhagen has a strong history of high-quality research in stem cell biology. Our researchers are leaders in their fields, with a strong record of scientific excellence.By building on this knowledge, reNEW is driving the advancement of effective treatments for unmet clinical needs.
Vision
to create a new generation of effective, safe, and socially sustainable stem cell-based therapies built on an international collaborative network of excellence in targeted biomedical research.
Mission
to develop an international targeted research center delivering innovative stem cell-driven therapies to transform the lives of people suffering from incurable disease.
reNEW in numbers
A unique international consortium
The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is an international consortium composed of three leading research institutions: the University of Copenhagen in Denmark, Leiden University Medical Centre in the Netherlands, and the Murdoch Children’s Research Institute in Australia.